Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
AngioDynamics, Inc.
AngioDynamics Reports Financial Results for Fiscal 2009 Third Quarter
April 21st, 2009
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative medical devices used by interventional radiologists and surgeons for the minimally-invasive treatment of cancer and peripheral vascular disease, reported financial results for the fiscal third quarter and nine months ended February 28, 2009. Financial results include the acquisition of Diomed assets since June 17, 2008, the date of acquisition, and the acquisition of FlowMedica assets since January 12, 2009, the date of acquisition. Net sales in the third quarter were $49.4 million, a 21% increase over the $40.7 million reported in the third quarter a year ago. Gross margin in the third quarter was...
Source: Cancer Weekly (2009-04-21)
|
